Management tracks: CASI promotes Zhang to president; plus Five Prime, Black Diamond, Oyster Point, Enyo, X4, Nimbus and Canbridge

Cancer and generics company CASI Pharmaceuticals Inc. (NASDAQ:CASI) promoted Larry Zhang to president. He was president of the cancer and generics company's Chinese subsidiary CASI Pharmaceuticals (Beijing) Co. Ltd. Prior to joining CASI, Zhang was VP and head

Read the full 382 word article

How to gain access

Continue reading with a
two-week free trial.